These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 4055045

  • 1. The use of cefotaxime in the treatment of gram-positive pneumonias.
    Jenkinson SG.
    Infection; 1985; 13 Suppl 1():S14-7. PubMed ID: 4055045
    [Abstract] [Full Text] [Related]

  • 2. An overview of cefotaxime therapy in infections caused by gram-positive pathogens.
    Iannini PB.
    Infection; 1985; 13 Suppl 1():S3-6. PubMed ID: 4055052
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The efficacy of cefotaxime in gram-positive surgical infections.
    Wittmann DH, Frommelt L.
    Infection; 1985; 13 Suppl 1():S37-42. PubMed ID: 4055054
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Ceftazidime versus cefotaxime in the therapy of severe infections in intensive care patients].
    Müller E, Heinkelein J.
    Infection; 1987; 15 Suppl 4():S173-8. PubMed ID: 3312030
    [Abstract] [Full Text] [Related]

  • 8. Clinical experience of cefotaxime in infections caused by gram-positive pathogens.
    Bassetti D, Solbiati M, Fraizzoli G.
    Infection; 1985; 13 Suppl 1():S112-4. PubMed ID: 4055040
    [Abstract] [Full Text] [Related]

  • 9. A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.
    Karakusis PH, Trenholme GM, Levin S.
    Infection; 1985; 13 Suppl 1():S46-9. PubMed ID: 4055055
    [Abstract] [Full Text] [Related]

  • 10. Cefotaxime for the treatment of gram-positive urinary tract infection.
    Piccinno A, Pagliarulo A.
    Infection; 1985; 13 Suppl 1():S100-2. PubMed ID: 4055038
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical experience with cefotaxime for the therapy of bacteremias due to gram-positive organisms.
    Schleupner CJ.
    Infection; 1985; 13 Suppl 1():S28-33. PubMed ID: 4055051
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical experience of cefotaxime (author's transl)].
    Portier H, Carbon C, Boussougant Y, Destaing F.
    Nouv Presse Med; 1981 Feb 26; 10(8):607-11. PubMed ID: 6259603
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cefotaxime monotherapy of bacterial meningitis caused by gram-positive pathogens.
    Helwig HF.
    Infection; 1985 Feb 26; 13 Suppl 1():S62-7. PubMed ID: 4055057
    [Abstract] [Full Text] [Related]

  • 19. Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patients.
    Yangco BG, Baird I, Lorber B, Noble R, Bermudez R, Silverblatt F, Vasquez G.
    J Antimicrob Chemother; 1987 Feb 26; 19(2):239-48. PubMed ID: 3553135
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.